Health In Tech, Inc. (HIT)

NASDAQ: HIT · USD

$0.61

+0.03 (+5.9%)· Recorded snapshot

Market cap	39.9M
Revenue (ttm)	32.8M
Net income (ttm)	-3.9M
EPS (ttm)	-$0.07
Shares out	65.5M
Volume	43,709

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 32.8M
Net income (ttm): -3.9M
EPS (ttm): -$0.07
Market cap: 39.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 19.8P75 31.4

Trailing P/En/a

P25 16.8P50 29.9P75 54

ROE-21.9

P25 -35.5P50 1.5P75 15.4

ROIC-42.9

P25 -18.6P50 1.9P75 14.1

Benchmarks · 1M

All HIT indicators

Market & fundamental data

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002019505
Company name	Health In Tech, Inc.
Country	United States
Country code	US
CUSIP number	42217D102
Earnings date	2026-11-09
Earnings time	amc
Employees	91
Employees change	11
Employees growth	13.75%
Enterprise value	$33.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1964
Industry	Software - Application
IPO date	2024-12-23
Is primary listing	Yes
Is SPAC	No
ISIN number	US42217D1028
Last 10-K release date	2026-03-25
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$39.9M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$0.61
Price currency	USD
Sector	Technology
SIC code	6411
Stock price date	2026-10-28
Symbol	HIT
U.S. state	Florida
Website	https://healthintech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-11.79%
EV/Sales	1.03x
FCF / EV yield	-15.08%
FCF yield	-12.68%
Forward EV/Sales	1x
Forward P/S	1.19x
Industry forward P/E	19.37x
Industry P/E	71.33x
P/B ratio	1.93x
P/S ratio	1.23x
Price / tangible book value	3.26x
Sector forward P/E	18.38x
Sector P/E	32.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-16.07%
Gross margin	53.93%
Operating margin	-16.07%
Pretax margin	-15.94%
Profit margin	-12.03%
Profit per employee	$-43,403
Profitable years	4
Revenue per employee	$360,736
ROA	-12.72%
ROCE	-26.84%
ROE	-21.91%
ROIC	-42.86%
SBC / revenue	5.16%
Tax / revenue	-3.91%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	-6.53%
Gross profit growth (Q)	-37.84%
Net income growth years	1
Revenue growth	22.98%
Revenue growth (Q)	-13.5%
Revenue growth (QoQ)	-8.15%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	$-5.3M
EPS	$-0.07
FCF per share	$-0.08
Financing cash flow	$6M
Free cash flow	$-5.1M
Free cash flow minus SBC	$-6.8M
Gross profit	$17.7M
Income taxes	$-1.3M
Investing cash flow	$-2.5M
Net cash flow	$-1.6M
Net income	$-3.9M
Operating cash flow minus SBC	$-6.8M
Operating income	$-5.3M
Revenue	$32.8M
Stock-based compensation	$1.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.42
Book value per share	$0.30
Debt / equity	0.01
Long-term assets	$7.9M
Long-term liabilities	$21,713
Net cash (debt)	$6.4M
Net cash / market cap	15.92%
Net cash growth	-19.49%
Net debt / equity	-0.33
Piotroski F-Score	0
Property, plant and equipment	$104,277
Shareholders' equity	$19.6M
Tangible book value	$12.4M
Tangible book value per share	$0.19
Total assets	$29.6M
Total cash	$6.5M
Total debt	$102,938
Total liabilities	$10M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.27
Current assets	$21.8M
Current liabilities	$10M
Current ratio	2.18
Net working capital	$5.4M
Quick ratio	1.85
Working capital	$11.8M
Working capital turnover	3.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.76%
Dividend yield	0%
Shareholder yield	-3.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.07
1D price change	5.91%
1M price change	-29.19%
1M total return	-29.19%
1W price change	1.48%
1W total return	1.48%
1Y price change	-77.69%
1Y return CAGR	-77.72%
1Y total return	-77.69%
20-day SMA	$0.67
200-day SMA	$1.16
3M price change	-44.13%
3M total return	-44.13%
50-day SMA	$0.82
50-day SMA vs 200-day SMA	50under200
52-week high	$3.11
52-week high date	2025-11-04
52-week low	$0.50
52-week low date	2026-10-21
6M price change	-59.4%
6M total return	-59.4%
All-time high	$7.59
All-time high date	2025-03-11
All-time low	$0.50
All-time low date	2026-10-21
Average true range (ATR)	$0.07
Average volume	116.4K
Beta (1Y)	0.85
Beta (2Y)	1.46
Change from 52-week high	-80.42%
Change from 52-week low	21.8%
Change from all-time high	-91.98%
Change from all-time low	21.8%
Change from open	5.02%
Day's gap	0.85%
Dollar volume	$26,619
High price	$0.61
Low price	$0.58
Monthly RSI	33.63
Open price	$0.58
Position in 52-week range	100%
Premarket change	0%
Premarket close	$0.58
Premarket price	$0.58
Previous close	$0.58
Price vs 150-day SMA	-43.03%
Price vs 20-day SMA	-9.16%
Price vs 200-day SMA	-47.45%
Price vs 50-day SMA	-26.06%
Relative volume	0.38
Return from IPO open	-88.3%
Return from IPO price	-84.64%
RSI	38.18
Sharpe ratio	-1.19
Sortino ratio	-1.52
Volume	43.7K
Weekly RSI	31.04
YTD price change	-61.7%
YTD total return	-61.7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12M
Float percentage	18.38%
Shares change (QoQ)	9.55%
Shares change (YoY)	3.76%
Shares held by insiders	81.62%
Shares held by institutions	7.26%
Shares outstanding	65.5M
Short % of float	3.51%
Short % of shares	0.65%
Short ratio	1.2 days

Deeper analysis on HIT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HIT report

Is a complete HIT research report available?

No complete published report is available for Health In Tech, Inc. (HIT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Health In Tech, Inc. (HIT)

Price

Financial snapshot

Fair-value bridge

Latest news · HIT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HIT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HIT

Frequently asked questions